Found: 235
Select item for more details and to access through your institution.
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study.
- Published in:
- Platelets, 2014, v. 25, n. 7, p. 517, doi. 10.3109/09537104.2013.842965
- By:
- Publication type:
- Article
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.
- Published in:
- Platelets, 2009, v. 20, n. 5, p. 341, doi. 10.1080/09537100903075324
- By:
- Publication type:
- Article
Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction.
- Published in:
- Chronobiology International: The Journal of Biological & Medical Rhythm Research, 2012, v. 29, n. 10, p. 1390, doi. 10.3109/07420528.2012.728658
- By:
- Publication type:
- Article
Short stay management of chest pain.
- Published in:
- Acta Cardiologica, 2011, v. 66, n. 2, p. 278
- By:
- Publication type:
- Article
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy.
- Published in:
- Population Health Management, 2024, v. 27, n. 6, p. 374, doi. 10.1089/pop.2024.0132
- By:
- Publication type:
- Article
Importance of Intensive Lipid Lowering in Acute Coronary Syndrome and Percutaneous Coronary Intervention.
- Published in:
- Journal of Interventional Cardiology, 2007, v. 20, n. 6, p. 447, doi. 10.1111/j.1540-8183.2007.00298.x
- By:
- Publication type:
- Article
Timing of Angiography and Revascularization in Acute Coronary Syndromes: An Analysis of the TACTICS-TIMI-18 Trial.
- Published in:
- Journal of Interventional Cardiology, 2004, v. 17, n. 2, p. 81, doi. 10.1111/j.1540-8183.2004.021001.x
- By:
- Publication type:
- Article
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials.
- Published in:
- EP: Europace, 2015, v. 17, n. 6, p. 855, doi. 10.1093/europace/euv001
- By:
- Publication type:
- Article
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e239638, doi. 10.1001/jamanetworkopen.2023.9638
- By:
- Publication type:
- Article
Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e234709, doi. 10.1001/jamanetworkopen.2023.4709
- By:
- Publication type:
- Article
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 16, p. 1711, doi. 10.1001/jama.2013.279206
- By:
- Publication type:
- Article
β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 13, p. 1340, doi. 10.1001/jama.2012.12559
- By:
- Publication type:
- Article
High-Density Lipoprotein Cholesterol as the Holy Grail.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 24, p. 2556, doi. 10.1001/jama.2011.860
- By:
- Publication type:
- Article
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI: A Meta-analysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 16, p. 1821, doi. 10.1001/jama.2010.1543
- By:
- Publication type:
- Article
Soft-tissue sarcoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639
- By:
- Publication type:
- Article
Individualized therapy in statin intolerance: the key to success.
- Published in:
- European Heart Journal, 2023, v. 44, n. 7, p. 544, doi. 10.1093/eurheartj/ehac556
- By:
- Publication type:
- Article
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
- Published in:
- European Heart Journal, 2023, v. 44, n. 4, p. 293, doi. 10.1093/eurheartj/ehac577
- By:
- Publication type:
- Article
A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
- Published in:
- European Heart Journal, 2023, v. 44, n. 3, p. 221, doi. 10.1093/eurheartj/ehac460
- By:
- Publication type:
- Article
Statin intolerance: how common is it and how do we work with patients to overcome it?
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3224, doi. 10.1093/eurheartj/ehac156
- By:
- Publication type:
- Article
Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events.
- Published in:
- Current Cardiology Reports, 2018, v. 20, n. 7, p. 1, doi. 10.1007/s11886-018-0997-4
- By:
- Publication type:
- Article
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?
- Published in:
- Current Atherosclerosis Reports, 2023, v. 25, n. 7, p. 381, doi. 10.1007/s11883-023-01112-3
- By:
- Publication type:
- Article
Periosteal margin in soft‐tissue sarcoma.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 3, p. 598, doi. 10.1002/cncr.22429
- By:
- Publication type:
- Article
Chemotherapy response is an important predictor of local recurrence in ewing sarcoma.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 3, p. 603, doi. 10.1002/cncr.22412
- By:
- Publication type:
- Article
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 10, p. 2455, doi. 10.1002/cncr.22298
- By:
- Publication type:
- Article
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
- By:
- Publication type:
- Article
Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3478, doi. 10.1111/dom.15687
- By:
- Publication type:
- Article
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1750, doi. 10.1111/dom.15032
- By:
- Publication type:
- Article
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
- By:
- Publication type:
- Article
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 758, doi. 10.1111/dom.14923
- By:
- Publication type:
- Article
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772
- By:
- Publication type:
- Article
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769
- By:
- Publication type:
- Article
Cost-Effectiveness of Clopidogrel.
- Published in:
- PharmacoEconomics, 2004, v. 22, p. 1, doi. 10.2165/00019053-200422004-00002
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Tenecteplase: Results from a Phase II Study in Patients with Acute Myocardial Infarction.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 5, p. 508, doi. 10.1177/009127000004000512
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Sibrafiban, an Orally Administered IIb/IIIa Antagonist, in Patients with Acute Coronary Syndrome.
- Published in:
- Journal of Clinical Pharmacology, 1999, v. 39, n. 7, p. 675, doi. 10.1177/00912709922008317
- By:
- Publication type:
- Article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
- By:
- Publication type:
- Article
Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Don't stop the statin!
- Published in:
- European Heart Journal, 2019, v. 40, n. 43, p. 3526, doi. 10.1093/eurheartj/ehz629
- By:
- Publication type:
- Article
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 19, p. 1553, doi. 10.1093/eurheartj/ehz059
- By:
- Publication type:
- Article
Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
- Published in:
- European Heart Journal, 2019, v. 40, n. 2, p. 218, doi. 10.1093/eurheartj/ehy679
- By:
- Publication type:
- Article
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials.
- Published in:
- European Heart Journal, 2018, v. 39, n. 42, p. 3810, doi. 10.1093/eurheartj/ehy556
- By:
- Publication type:
- Article
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration.
- Published in:
- European Heart Journal, 2018, v. 39, n. 27, p. 2540, doi. 10.1093/eurheartj/ehx450
- By:
- Publication type:
- Article
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
- Published in:
- European Heart Journal, 2018, v. 39, n. 19, p. 1726, doi. 10.1093/eurheartj/ehy162
- By:
- Publication type:
- Article
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
- Published in:
- European Heart Journal, 2017, v. 38, n. 37, p. 2813, doi. 10.1093/eurheartj/ehx250
- By:
- Publication type:
- Article
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
- Published in:
- European Heart Journal, 2016, v. 37, n. 48, p. 3576, doi. 10.1093/eurheartj/ehw377
- By:
- Publication type:
- Article
Galectin-3 and the Development of Heart Failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22.
- Published in:
- Clinical Chemistry, 2012, v. 58, n. 1, p. 267, doi. 10.1373/clinchem.2011.174359
- By:
- Publication type:
- Article
Clopidogrel: To Test or Not to Test? That Is the Question--Still.
- Published in:
- Clinical Chemistry, 2011, v. 57, n. 5, p. 659, doi. 10.1373/clinchem.2010.158709
- By:
- Publication type:
- Article